Xinqiao Hospital of Chongqing clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.
- Notable: INSTANT-2 · Non-inferiority Clinical Trial With Blinded Endpoint Assessment of Early Tirofiban After Intravenous Thrombolysis in Acute Ischemic Stroke Start date pushed from Nov 19, 2026 to Dec 19, 2026
- Notable: COOLING · Role of Hypothermia in Endovascular Stroke Thrombectomy Enrollment reduced: 200 → 100 participants
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Early Phase 1 | 3 | |
| Phase 1/2 | 1 | |
| Phase 2 | 4 | |
| Phase 2/3 | 1 | |
| Phase 3 | 2 | |
| Phase 4 | 3 |
Not charted: 6 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Stroke (8) · Lung Cancer (5) · Non-Small Cell Lung Cancer (NSCLC) (4) · Colorectal Cancer (1) · Head & Neck Cancer (1)
Get alerts when Xinqiao Hospital of Chongqing's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.